Effects of a Long-Acting Formulation of Octreotide on Patients with Portal Hypertension

Table 4

Live functions at baseline.

	TIPS ()	OCT-LAR ()
AST (U/L)	94.6 ± 49.3	97.2 ± 37.3	0.89
ALT (U/L)	101.3 ± 57.2	100.8 ± 35.3	0.98
TB (μmol/L)	64.7 ± 16.9	51.9 ± 16.3	0.07
Prothrombin time (s)	17.6 ± 1.3	18.1 ± 1.8	0.51